Disease/Infection News

RSS

Also in global health news: Aid in S. Somalia; virus-resistant mosquitoes; composting toilets in Haiti; U.S. Congressional Group visits India

The U.N. World Food Program (WFP) announced Tuesday that it has been forced to halt "aid distribution to about 1 million people in southern Somalia because of attacks against staff and demands by armed groups that aid groups remove women from their teams," the Associated Press reports.

5 Jan 2010

Circumcision lowers HIV risk; changes bacterial community on penis microbiome

Circumcision, which substantially lowers HIV risk in men, also dramatically changes the bacterial communities of the penis, according to a study led by scientists at the Translational Genomics Research Institute (TGen) and Johns Hopkins University and published Jan. 6 in the scientific journal PLoS ONE.

5 Jan 2010

AHF launches second HIV Testing Tour across the US

In an effort to raise local and national awareness about the importance—and ease—of HIV testing and to challenge attitudes about moving toward a streamlined model of HIV testing and counseling nationwide, AIDS Healthcare Foundation (AHF) is proud to report its launch of a second HIV Testing Tour across the US after its successful completion of its recent and ambitious 14 city AHF Magic Johnson HIV Testing Caravan in mid-2009.

5 Jan 2010

$HIV-infected postmenopausal women face higher risk for accelerated bone loss and fracture$

HIV-infected postmenopausal women face higher risk for accelerated bone loss and fracture

According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), postmenopausal HIV-infected women have a high prevalence of low bone mineral density and high bone turnover placing them at high risk for future bone fractures.

5 Jan 2010

LifeVantage announces Protandim human clinical trials for non-alcoholic steatohepatitis

LifeVantage Corporation, the maker of Protandim® and TrueScience(TM) Anti-Aging Cream, science-based solutions to oxidative stress, announced today that the Company's flagship product, Protandim, a patented dietary supplement composed of five highly synergistic "indirect antioxidants", is currently the subject of two human clinical trials at the University of Colorado, Denver.

5 Jan 2010

HHS to host special flu webcast on Jan 6, 2010

The U.S. Department of Health and Human Services (HHS) will host a Know What to Do about the Flu Webcast on Wednesday, January 6, 2010 from 1 – 2 p.m. EST.

5 Jan 2010

January issue of Chest presents new studies on COPD

A new study shows that poor lung function during adolescence and through midlife may be influenced by several factors, including birth weight, height, and gender.

5 Jan 2010

Scientists develop mucus-penetrating biodegradable nanoparticles to deliver drugs over time

Johns Hopkins University researchers have created biodegradable nanosized particles that can easily slip through the body's sticky and viscous mucus secretions to deliver a sustained-release medication cargo.

5 Jan 2010

Coformulation of rilpivirine and Truvada HIV drugs will achieve sales of more than $2 billion in 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2018, the fixed dose coformulation of Tibotec's rilpivirine and Gilead's Truvada will achieve blockbuster sales of more than $2 billion in the HIV drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

5 Jan 2010

Department of Health urges Pennsylvanians to get vaccinated against H1N1 flu

All Pennsylvanians are urged to take advantage of the increasing supply of H1N1 vaccine by getting immunized at the upcoming vaccination clinics being offered by the Department of Health.

5 Jan 2010

Research shows licorice root might be effective in fighting antibiotic-resistant infections

A team of scientists from the University of Texas Medical Branch and Shriners Hospitals for Children show how a compound from licorice root (glycyrrhizin from Glycyrrhiza glabra) might be an effective tool in battling life-threatening, antibiotic-resistant infections resulting from severe burns.

5 Jan 2010

Study examines relationship between parental vaccine refusal and risk of varicella infection in children

Children of parents who refuse vaccines are nine times more likely to get chickenpox compared to fully immunized children, according to a new study led by a vaccine research team at Kaiser Permanente Colorado's Institute for Health Research.

5 Jan 2010

NPR examines future of U.S. global AIDS strategy

NPR's "All Things Considered" examines the Obama administration's global HIV/AIDS policy. "Instead of relying on one program, such as the President's Emergency Plan for AIDS Relief or PEPFAR, [U.S. Global AIDS Coordinator Eric] Goosby says the U.S. has a new five-year strategy that would help low and middle income countries build their own health care systems that incorporate international health programs," according to NPR.

5 Jan 2010

New York Times examines U.S. H1N1 reponse

As the number of H1N1 (swine flu) cases in the U.S. continues to wane, the New York Times reflects on how federal officials handled the pandemic and other contributing factors.

5 Jan 2010

AP series examines worldwide impact of drug resistance

The Associated Press reports on how the misuse of drugs worldwide has contributed to drug-resistant diseases in a series of articles following a six-month investigation by the news service.

5 Jan 2010

Peginterferon alpha-2a yields better results in treating patients with chronic hepatitis C

In patients with chronic hepatitis C, treatment with peginterferon alpha-2a (PegIFNα2a) plus ribavirin (RBV) better suppresses the virus to undetectable levels in the blood than treatment with peginterferon alpha-2b (PegIFNα2b) plus RBV, according to two new head-to-head studies in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

5 Jan 2010

GIVI scientists discover anti-HIV molecule that enhances infection, reduces transmission

Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have discovered a new agent that might inhibit the infectivity of HIV. The agent, surfen, impairs the action of a factor in semen that greatly enhances the viral infection.

5 Jan 2010

Positive results from Pearl Therapeutics' PT005 Phase 2a trial for COPD

Pearl Therapeutics Inc., a company developing high-quality combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from its first clinical trial in patients with chronic obstructive pulmonary disease (COPD).

5 Jan 2010

Independent examines diseases that jump from animals to humans

The Independent examines the expansion of human diseases that originated in animals. "At least 45 diseases that have passed from animals to humans have been reported to U.N. agencies in the last two decades, with the number expected to escalate in the coming years," the Independent writes.

5 Jan 2010

Elusys Therapeutics signs contract to complete the final development of Anthim

Elusys Therapeutics, Inc. (Elusys), a privately-held biopharmaceutical company, announced today that it has signed a contract potentially totaling up to $143 million to complete the final development, commercial manufacturing and licensure of Anthim, the company's late stage anthrax therapeutic.

5 Jan 2010

Disease/Infection News

Also in global health news: Aid in S. Somalia; virus-resistant mosquitoes; composting toilets in Haiti; U.S. Congressional Group visits India

Circumcision lowers HIV risk; changes bacterial community on penis microbiome

AHF launches second HIV Testing Tour across the US

HIV-infected postmenopausal women face higher risk for accelerated bone loss and fracture

LifeVantage announces Protandim human clinical trials for non-alcoholic steatohepatitis

HHS to host special flu webcast on Jan 6, 2010

January issue of Chest presents new studies on COPD

Scientists develop mucus-penetrating biodegradable nanoparticles to deliver drugs over time

Coformulation of rilpivirine and Truvada HIV drugs will achieve sales of more than $2 billion in 2018

Department of Health urges Pennsylvanians to get vaccinated against H1N1 flu

Research shows licorice root might be effective in fighting antibiotic-resistant infections

Study examines relationship between parental vaccine refusal and risk of varicella infection in children

NPR examines future of U.S. global AIDS strategy

New York Times examines U.S. H1N1 reponse

AP series examines worldwide impact of drug resistance

Peginterferon alpha-2a yields better results in treating patients with chronic hepatitis C

GIVI scientists discover anti-HIV molecule that enhances infection, reduces transmission

Positive results from Pearl Therapeutics' PT005 Phase 2a trial for COPD

Independent examines diseases that jump from animals to humans

Elusys Therapeutics signs contract to complete the final development of Anthim

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News